Earnings Alert: BioMarin Reports Strong Q3 Growth Amid Surge in VOXZOGO Sales
Daily NewsBioMarin Pharmaceutical Inc. (BMRN) reported a significant increase in revenues in the third quarter of 2024, driven by a substantial rise in sales of the achondr...
Read More